ID
45656
Descrição
Principal Investigator: Jeffrey S. Weber, MD, PhD, Donald A. Adam Comprehensive Melanoma Research Center, Moffitt Cancer Center, Tampa, Florida, USA MeSH: Melanoma https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001241 This study contains sequence data from 15 patients with stage IV melanoma, including the whole genome sequence of 15 metastatic tumors and corresponding normal blood samples from 13 cases, and targeted capture sequence of four synchronous metastatic samples from two additional cases. These data provide a comprehensive survey of the clonal architecture and associated driver mutations in metastatic melanoma.
Link
Palavras-chave
Versões (1)
- 21/03/2023 21/03/2023 - Simon Heim
Titular dos direitos
Jeffrey S. Weber, MD, PhD, Donald A. Adam Comprehensive Melanoma Research Center, Moffitt Cancer Center, Tampa, Florida, USA
Transferido a
21 de março de 2023
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
dbGaP phs001241 Clonal Architectures and Driver Mutations in Metastatic Melanomas
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, and affection status of participants with melanoma and involved in the "Clonal Architectures and Driver Mutations in Metastatic Melanomas" project.
- Subject ID, sample ID, and sample use variable obtained from participants with melanoma and involved in the "Clonal Architectures and Driver Mutations in Metastatic Melanomas" project.
- Subject ID, age, and gender of participants with melanoma and involved in the "Clonal Architectures and Driver Mutations in Metastatic Melanomas" project.
- Sample ID, analyte type, body site where sample was obtained, histological type of sample, and tumor status of sample obtained from participants with melanoma and involved in the "Clonal Architectures and Driver Mutations in Metastatic Melanomas" project.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, and affection status of participants with melanoma and involved in the "Clonal Architectures and Driver Mutations in Metastatic Melanomas" project.
- Subject ID, sample ID, and sample use variable obtained from participants with melanoma and involved in the "Clonal Architectures and Driver Mutations in Metastatic Melanomas" project.
- Subject ID, age, and gender of participants with melanoma and involved in the "Clonal Architectures and Driver Mutations in Metastatic Melanomas" project.
- Sample ID, analyte type, body site where sample was obtained, histological type of sample, and tumor status of sample obtained from participants with melanoma and involved in the "Clonal Architectures and Driver Mutations in Metastatic Melanomas" project.
C0680251 (UMLS CUI [1,2])
C1706256 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,3])
C1321872 (UMLS CUI [1,4])